^
+ Follow UPPSALA UNIVERSITY Tag
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1386241
                    [Title] => Pag-inom ng gatas, nakakamatay?
                    [Summary] => 

Maraming nagsasabi na ang pag-inom ng gatas ay nakakapatibay ng buto.

[DatePublished] => 2014-10-31 00:00:00 [ColumnID] => 0 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Para Malibang [SectionUrl] => para-malibang [URL] => ) [1] => Array ( [ArticleID] => 1369717 [Title] => Why you should keep plants in the office [Summary] =>

We all know that adding few potted plants bring a comfortable feel to your work space. But apart from the visual appeal that plants provide, there are much more reasons why you should put a touch of green on your desk. 

[DatePublished] => 2014-09-16 11:26:13 [ColumnID] => 0 [Focus] => 0 [AuthorID] => 1121281 [AuthorName] => Alixandra Caole Vila [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => http://media.philstar.com/images/the-philippine-star/lifestyle/health-and-family/20140916/potted-plants-office.jpg ) [2] => Array ( [ArticleID] => 322917 [Title] => Pinoy docs in most extensive anti-blood clot clinical trial [Summary] => Boehringer-Ingelheim has launched the biggest ever thromboembolic disease clinical trial program.

The trials under the umbrella name RE-VOLUTION and involving more than 27,000 patients worldwide, will investigate a novel oral direct thrombin inhibitor, dabigatran etexilate, researched and developed by the Germany-based pharmaceutical company to prevent and treat thromboembolic disease.

Dabigatran etexilate is a promising new oral direct thrombin inhibitor that specifically and reversibly inhibits thrombin, the key enzyme for blood clot formation.
[DatePublished] => 2006-02-23 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
UPPSALA UNIVERSITY
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1386241
                    [Title] => Pag-inom ng gatas, nakakamatay?
                    [Summary] => 

Maraming nagsasabi na ang pag-inom ng gatas ay nakakapatibay ng buto.

[DatePublished] => 2014-10-31 00:00:00 [ColumnID] => 0 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Para Malibang [SectionUrl] => para-malibang [URL] => ) [1] => Array ( [ArticleID] => 1369717 [Title] => Why you should keep plants in the office [Summary] =>

We all know that adding few potted plants bring a comfortable feel to your work space. But apart from the visual appeal that plants provide, there are much more reasons why you should put a touch of green on your desk. 

[DatePublished] => 2014-09-16 11:26:13 [ColumnID] => 0 [Focus] => 0 [AuthorID] => 1121281 [AuthorName] => Alixandra Caole Vila [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => http://media.philstar.com/images/the-philippine-star/lifestyle/health-and-family/20140916/potted-plants-office.jpg ) [2] => Array ( [ArticleID] => 322917 [Title] => Pinoy docs in most extensive anti-blood clot clinical trial [Summary] => Boehringer-Ingelheim has launched the biggest ever thromboembolic disease clinical trial program.

The trials under the umbrella name RE-VOLUTION and involving more than 27,000 patients worldwide, will investigate a novel oral direct thrombin inhibitor, dabigatran etexilate, researched and developed by the Germany-based pharmaceutical company to prevent and treat thromboembolic disease.

Dabigatran etexilate is a promising new oral direct thrombin inhibitor that specifically and reversibly inhibits thrombin, the key enzyme for blood clot formation.
[DatePublished] => 2006-02-23 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
abtest
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

Get Updated:

Signup for the News Round now

FORGOT PASSWORD?
SIGN IN
or sign in with